netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Hydrocortisone found 19 matches

Formulary items 18 matches
   
Open monograph to display formulary status BNF Category
  Hydrocortisone Endocrine system - Glucocorticoid therapy - 06.03.02
  Hydrocortisone acetate 25mg in 1ml injection Musculoskeletal and joint diseases - Local corticosteroids injections - 10.01.02.02
  Hydrocortisone sodium phosphate  (Efcortesol®) Endocrine system - Glucocorticoid therapy - 06.03.02
  Hydrocortisone sodium succinate
(Injection)
Endocrine system - Replacement therapy - 06.03.01
  Hydrocortisone 1% Skin - Mild - 13.04
  Hydrocortisone 1% Neomycin 0.439% & Polymixin B sulphate 10,000iu/ml ear drops  (Otosporin®) Ear, nose and oropharynx - Anti-inflammatory preparations - 12.01.01
  Hydrocortisone 1% with Clotrimazole 1%  (Canesten HC®) Skin - Mild - 13.04
  Hydrocortisone 1%, Oxytetracycline 3%   (Terra-Cortril ®) Skin - Mild - 13.04
  Hydrocortisone 10 mg, and 20mg tablets Endocrine system - Replacement therapy - 06.03.01
  Hydrocortisone Acetate 1% with Fusidic Acid 2%  (Fucidin H®) Skin - Mild - 13.04
  Hydrocortisone Acetate 1% with Gentamicin 0.3%  (Gentisone® HC) Ear, nose and oropharynx - Anti-inflammatory preparations - 12.01.01
  Hydrocortisone Butyrate 0.1% cream  (Locoid®) Skin - Moderate - 13.04
  Hydrocortisone Butyrate 0.1% ointment  (Locoid®) Skin - Moderate - 13.04
  Hydrocortisone Sodium Phosphate  (Softacort®) Eye - Corticosteroids - 11.04.01
  Nystatin 100,000 I.U./g, Chlorhexidine acetate 1.0% w/w, Hydrocortisone 0.5% w/w  (Nystaform-HC cream ®) Skin - Mild - 13.04
  Nystatin 100,000 I.U./g, Chlorhexidine acetate 1.0% w/w, Hydrocortisone 1.0% w/w  (Nystaform-HC ointment ®) Skin - Mild - 13.04
  Proctosedyl® Gastro-intestinal system - Compound haemorrhoidal preparations with corticosteroids - 01.07.02
  Whitmore cocktail Obstetrics, Gynaecology, and urinary-tract disorders - Bladder instillations and urological surgery - 07.04.04
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Feb 2021): Alkindi (hydrocortisone granules): risk of acute adrenal insufficiency in children when switching from hydrocortisone tablet formulations to granules (06.03.02)


 

netFormulary